Skip to main content

Table 2 Factorial analysis of spike protein antibody titers > 137 at 90 days (univariate analysis)

From: Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients

Item

 > 137 (n = 53)

 ≤ 137 (n = 28)

p

Height (cm)

163.2 ± 8.8

161.3 ± 12.6

0.411

Body weight (kg)

61.5 ± 16.4

61.1 ± 15.5

0.911

Body Mass Index (kg/m2)

23 ± 5.6

23.6 ± 6.5

0.666

History of dialysis (years)

5.4 ± 4.7

3.7 ± 2.8

0.085

Creatinine Index

93.6 ± 24.1

85.9 ± 25.8

0.185

C-reactive protein (mg/dL)

0.5 ± 1.5

0.3 ± 0.4

0.571

HbA1c (NGSP) (%) note

6.5 ± 1.4

6.3 ± 1.6

0.615

PTH-intact (pg/mL)

194 ± 125.6

172.9 ± 101.8

0.447

Glycated albumin (%) note

20.7 ± 3.9

21.9 ± 6.5

0.493

Ferritin (ng/mL)

184.3 ± 186.3

190 ± 167.7

0.893

Geriatric Nutritional Risk Index

94.1 ± 7.3

92.1 ± 7.8

0.248

Kt/V (shinzato)

1.4 ± 0.2

1.4 ± 0.3

0.230

Protein catabolism rate (g/kg/day)

0.9 ± 0.1

0.8 ± 0.2

0.340

Transferrin saturation (%)

29.3 ± 16.8

28.9 ± 13.5

0.896

Pre-dialysis albumin (g/dL)

3.7 ± 0.3

3.5 ± 0.4

0.013 *

Clear space ratio (%)

66.6 ± 6.4

64.4 ± 8.1

0.181

Post-dialysis albumin (g/dL)

4.4 ± 0.6

4.2 ± 0.6

0.131

Age (years)

65.7 ± 14.9

73.8 ± 14.1

0.020 *

Sex (Male/Female)

39 (73.6%)/14 (26.4%)

21 (75%)/7 (25%)

0.890

Diabetes

19 (35.8%)

13 (46.4%)

0.354

Nephrosclerosis

15 (28.3%)

9 (32.1%)

0.719

Chronic glomerulonephritis

10 (18.9%)

2 (7.1%)

0.158

  1. Note: n = 22(> 137), n = 14(≤ 137)
  2. *p < 0.05 Student’s t-test
  3. (Unless otherwise specified, the last pre-dialysis values before the first vaccine dose are shown.)